Emgality (Galcanezumab PFS) 120 mg/mL

EMGALITY (galcanezumab) 120 mg/mL is a prescription injection for migraine prevention. Store between 2-8°C to maintain potency. This monoclonal antibody targets CGRP for episodic cluster headache treatment. Ideal for adults seeking preventive migraine relief.

Strength

120 mg/mL

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

EMGALITY is used to prevent migraines in adults, reducing the frequency of attacks. It is also prescribed for episodic cluster headache prevention. This medication works by blocking calcitonin gene-related peptide (CGRP) activity. Patients may use it alongside other migraine management strategies for improved outcomes.

Side Effects

Many users report fewer and less severe migraine days after starting EMGALITY. Some experience reduced reliance on acute pain relief medications. Common effects include injection site reactions like redness or discomfort. These effects are typically mild and temporary.

Precautions & Warnings

Keep EMGALITY refrigerated between 2-8°C and protect from light. Do not freeze or shake vigorously. Inspect the prefilled syringe for particles or discoloration before use. Discard any unused portion after use. Consult a healthcare provider if you have latex sensitivity.

Avoid Interactions

EMGALITY has no known direct drug interactions, but always inform your doctor about all medications. Live vaccines may have reduced effectiveness during treatment. Monitor for infections as this medication affects the immune system. Alcohol and certain foods do not interact but may worsen migraine symptoms.

Frequently Asked Questions

EMGALITY is used to prevent migraines in adults and treat episodic cluster headaches.

EMGALITY is given as a subcutaneous injection once monthly.

Common side effects include injection site reactions like redness or pain.

EMGALITY requires a prescription and is available through licensed pharmacies.

Store EMGALITY between 2-8°C in the refrigerator and protect from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.